This work demonstrates the dynamic potential for tailoring the surface plasmon resonance (SPR), size, and shapes of gold nanoparticles (AuNPs) starting from an Au(I) precursor, chloro(dimethyl sulfide)gold (I) (Au(Me2S)Cl), in lieu of the conventional Au(III) precursor hydrogen tetrachloroaurate (III) hydrate (HAuCl4). Our approach presents a one-step method that permits regulation of an Au(I) precursor to form either visible-absorbing gold nanospheres or near-infrared-window (NIRW)-absorbing anisotropic AuNPs. A collection of shapes is obtained for the NIR-absorbing AuNPs herein, giving rise to spontaneously formed nanomosaic (NIR-absorbing anisotropic gold nanomosaic, NIRAuNM) without a dominant geometry for the tesserae elements that comprise the mosaic. Nonetheless, NIRAuNM exhibited high stability; one test sample remains stable with the same SPR absorption profile 7 years post-synthesis thus far. These NIRAuNM are generated within thermoresponsive poly(N-isopropylacrylamide) (PNIPAm) microgels, without the addition of any growth-assisting surfactants or reducing agents. Our directed-selection methodology is based on the photochemical reduction of a light-, heat-, and water-sensitive Au(I) precursor via a disproportionation mechanism. The NIRAuNM stabilized within the thermoresponsive microgels demonstrates a light-activated size decrease of the microgels. On irradiation with a NIR lamp source, the percent decrease in the size of the microgels loaded with NIRAuNM is at least five times greater compared to the control microgels. The concept of photothermal shrinkage of hybrid microgels is further demonstrated by the release of a model luminescent dye, as a drug release model. The absorbance and emission of the model dye released from the hybrid microgels are over an order of magnitude higher compared to the absorbance and emission of the dye released from the unloaded-control microgels.
In this communication, we present a streamlined, reproducible synthetic method for the production of size-tunable poly(methyl methacrylate) (PMMA) nanoparticles (PMMANPs) and amine-functionalized block-copolymer PMMANPs (H2N-PMMANPs) by varying subcritical concentrations (i.e., below the concentration required to form micelles at 1 atm and 20 °C) of sodium dodecyl sulfate (SDS). We plotted the Z-average size data against SDS concentration, which revealed a second-order exponential decay function, expressed as . The surfactant concentration (wt./wt.%) has been selected as independent variable x. This function is valid at least for the size range of 20 nm to 97 nm (PMMANPs) and 20 nm to 133 nm (H2N-PMMANPs).
Glioblastoma multiforme is an aggressive, invasive, fatal primary heterogenic brain tumor. New treatments have not significantly improved the dismal survival rate. Low-level laser therapy reports indicate different tumor cells respond distinctly to low-level laser therapy based on laser dose (J/cm2) or with nanotherapeutics. We investigated the effects of pairing two optical property-driven treatment agents—a low-level laser on glioblastoma multiforme (U251) using an He-Ne laser (632.8 nm) with 18.8 nm spherical Ag-PMMA-PAA nanoparticles, with an absorbance peak at 400 nm with a broad shoulder to 700 nm. The He-Ne treatment parameters were power (14.87 ± 0.3 mW), beam diameter (0.68 cm), and exposure time 5 min leading to a 12.28 J/cm2 dose. A dose of 12.28 J/cm2 was applied to Ag-PMMA-PAA nanoparticle concentrations (110–225 μM). An amount of 110 μM Ag-PMMA-PAA nanoparticles combined with an He-Ne dose at 18 h yielded 23% U251 death compared to He-Ne alone which yielded 8% U251 death. A 225 μM Ag-PMMA-PAA nanoparticle He-Ne combination resulted in an earlier, more significant, U251 death of 38% at 6 h compared to 30% with 225 μM alone at 18 h. Both treatment agents possess inherent physical and functional properties capable of redesign to enhance the observed cell death effects. Our results provide evidence supporting next-step studies to test “the redesign hypothesis” that these paired optical-driven agents provide a tunable platform that can generate significant U251 cell death increase.